Janssen Violated FCA, State Laws In HIV Drug Promotions, N.J. Federal Jury Says

NEWARK, N.J. — A New Jersey federal jury found that Janssen Products LP violated federal and various state false claims laws in its promotion of HIV drugs Prezista and Intelence and...

Already a subscriber? Click here to view full article